MGD019 DART® Protein in Unresectable/Metastatic Cancer

NCT03761017 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

162

Enrollment

INDUSTRY

Sponsor class

Conditions

Squamous Cell Non Small Cell Lung Cancer
Prostate Cancer Metastatic
Cutaneous Melanoma
Colorectal Cancer
Advanced Cancer
Solid Tumor, Adult

Interventions

BIOLOGICAL: Lorigerlimab

Sponsor

MacroGenics